by Juliette Boynton | Mar 1, 2019 | Briefings, UK
Technetix was the proprietor of a patent for a cable tap, namely a unit which subdivides a cable TV signal arriving at a street cabinet to individual feeds for individual houses. Cable taps incorporate directional coupler units which reduce the strength of the cable...
by Carolyn Haywood | Mar 1, 2019 | Briefings, UK
Background Genentech is the proprietor of European patent (UK) No. 1 641 822 entitled “Il-17A/F heterologous peptides and therapeutic uses thereof”. Genentech does not at present have a product covered by the patent but Lilly market an antibody under the...
by Carolyn Haywood | Mar 1, 2019 | Briefings
Background Genentech is the proprietor of European patent (UK) No. 1 641 822 entitled “Il-17A/F heterologous peptides and therapeutic uses thereof”. Genentech does not at present have a product covered by the patent but Lilly market an antibody under the...
by Alex Bajjon | Feb 1, 2019 | Briefings, UK
Introduction This case relates to a European patent (EP2269603) in the name of Novartis relating to derivatives of rapamycin. Claim 1 of the patent covers: “40-O-(2-hydroxyethyl)-rapamycin in combination with exemestane for use in the treatment of hormone...
by David Eyre | Feb 1, 2019 | Briefings, EPO
Can you patent a genetically modified organism? While Article 53(b) EPC is clear that essentially biological methods of producing an organism, i.e. crossing and selection, are not patentable there has been ongoing debate as to whether the organisms resulting from...
by Carolyn Haywood | Feb 1, 2019 | Briefings
Almost two years after the signing of the agreement Helsinn filed a US provisional patent application, which ultimately lead to four patents. One of these patents, the ‘219 patent, being a continuation of the original application, specifically referred to a...
Recent Comments